Malabsorption Clinical Trials

14 recruitingLast updated: May 13, 2026

There are 14 actively recruiting malabsorption clinical trials across 8 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4. Top locations include Boston, Massachusetts, United States, Netanya, Israel, Aurora, Colorado, United States. Updated daily from ClinicalTrials.gov.


Malabsorption Trials at a Glance

14 actively recruiting trials for malabsorption are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Boston, Netanya, and Aurora. Lead sponsors running malabsorption studies include Boston Children's Hospital, Elgan Pharma Ltd., and Asger Lund, MD.

Browse malabsorption trials by phase

Treatments under study

About Malabsorption Clinical Trials

Looking for clinical trials for Malabsorption? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Malabsorption trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Malabsorption clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 2

Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA

Intestinal Malabsorption
Elgan Pharma Ltd.60 enrolled1 locationNCT05904626
Recruiting

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

Hepatocellular CarcinomaHIV InfectionsCirrhosis, Liver+6 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS20 enrolled1 locationNCT07429864
Recruiting
Not Applicable

Elemental 028 Extra Case Studies

MalabsorptionAllergiesGastrointestinal Disease+3 more
Nutricia UK Ltd30 enrolled1 locationNCT06877923
Recruiting
Phase 2

Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants

Iron-Deficiency AnemiaIron-deficiencyPrematurity+1 more
University of Washington120 enrolled1 locationNCT05340465
Recruiting
Not Applicable

Probiotic in Patients With Bile Acid Malabsorption/Diarrhea

Bile Acid MalabsorptionBile Acid Diarrhea
Mayo Clinic24 enrolled1 locationNCT06609148
Recruiting
Phase 3

Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants

Intestinal Malabsorption
Elgan Pharma Ltd.360 enrolled1 locationNCT05670951
Recruiting

Magnesium in Gastrointestinal Disease

Ileostomy - StomaBile Acid MalabsorptionColitis Ulcerative+9 more
University of Aarhus120 enrolled1 locationNCT07338565
Recruiting
Not Applicable

A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB

MalabsorptionShort Bowel Syndrome
Boston Children's Hospital32 enrolled1 locationNCT03530852
Recruiting
Phase 4

Treatment of Bile Acid Diarrhoea With Atorvastatin

Bile Acid MalabsorptionBile Acid Diarrhea
Asger Lund, MD20 enrolled1 locationNCT07042165
Recruiting
Phase 2

Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)

Short Bowel SyndromeFunctional Gastrointestinal DisordersPost-Op Complication+2 more
Napo Therapeutics, S.p.A.18 enrolled8 locationsNCT06904872
Recruiting
Not Applicable

Immune Responses to Gluten

Celiac DiseaseCeliac Disease in ChildrenIntestinal Disease+4 more
Boston Children's Hospital400 enrolled2 locationsNCT05209568
Recruiting

Protein Digestion After Bariatric Surgery in Older Adults

AgingOverweight and ObesityBariatric Surgery Candidate+1 more
Universitaire Ziekenhuizen KU Leuven72 enrolled2 locationsNCT06076187
Recruiting

Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance

Lactose intoleranceLactose IntolerantLactose Malabsorption
European Institute of Oncology385 enrolled1 locationNCT06773650
Recruiting

Bile Acids and Microbiome in Early Colorectal Carcinogenesis

Colorectal, CancerColorectal NeoplasmsColorectal Polyp+2 more
Vilnius University60 enrolled1 locationNCT06502704